In hepatocellular carcinoma, miR-9-5p levels are elevated, and this miRNA enhances the stemness and anoikis resistance of cancer cells by targeting polypeptide N-acetylgalactosaminyltransferase 4 (GALNT4) (Figure 1 and Table 1). The gene discussed is GALNT4; the disease is hepatocellular carcinoma.